发明申请
US20110045537A1 Human Anti-IFN-gamma Neutralizing Antibodies as Selective IFN-gamma Pathway Inhibitors
有权
人抗IFN-γ中和抗体作为选择性IFN-γ途径抑制剂
- 专利标题： Human Anti-IFN-gamma Neutralizing Antibodies as Selective IFN-gamma Pathway Inhibitors
- 专利标题（中）： 人抗IFN-γ中和抗体作为选择性IFN-γ途径抑制剂
-
申请号： US12831087申请日： 2010-07-06
-
公开(公告)号： US20110045537A1公开(公告)日： 2011-02-24
- 发明人: Andrew A. Welcher , Hilary T. Chute , Yue-Sheng "Luke" Li , Haichun Huang
- 申请人： Andrew A. Welcher , Hilary T. Chute , Yue-Sheng "Luke" Li , Haichun Huang
- 申请人地址： US CA Thousand Oaks
- 专利权人： AMGEN INC.
- 当前专利权人： AMGEN INC.
- 当前专利权人地址： US CA Thousand Oaks
- 主分类号： C12P21/08
- IPC分类号： C12P21/08 ; C07H21/00 ; C12N5/10
摘要：
This invention provides antibodies that interact with or bind to human interferon-gamma (IFN-γ) and methods for treating IFN-γ mediated diseases by administering a pharmaceutically effective amount of antibodies to IFN-γ. Methods of detecting the amount of IFN-γ in a sample using antibodies to IFN-γ are also provided.
公开/授权文献
信息查询
